Carerx Corporation · TSX:CRRX

Carerx — Investor Presentation (June 2025)

16 slides from Carerx's investor presentation, Jun 2, 2025

  1. Slide 1: Investor Presentation June 2025

    INVESTOR PRESENTATION June 2025 TSX: CRRX

  2. Slide 2: Forward Looking Statements

    Forward Looking Statements Certain of the statements contained in this presentation are "forward looking information within the meaning of applicable Canadian securities legislation. Forward looking information includes, but is not limited to, business strategy, plans and other expectations, beliefs

  3. Slide 3: Canada's leading provider of specialty pharmacy services to seniors housing communities

    Canada’s leading provider of specialty pharmacy services to seniors housing communities Enhancing the health of seniors with complex medication needs with high-touch, same-day delivery of specially packaged medications 3

  4. Slide 4: Canadian Market

    Canadian Market 1 in 5 Typical Seniors in Adults 65+ consume Canadians long-term care take ~40% are aged 4 to 12 of prescription drugs & medications daily ~25% 65 or older of OTC drugs Source: Statistics Canada 4 An aging population is driving unprecedented demand for medications and care services i

  5. Slide 5: Operational and Financial Highlights

    Operational and Financial Highlights ~88,000 ~1,450 Nationwide Footprint Beds serviced Seniors housing communities served 26 5+ Fulfillment centres Year average contract term with our largest customers CareRx Tripled Bed count ~88,000 since 2020 $89.6M $7.8M 8.7% 2025 Q1 2025 Revenue Q1 2025 Q1 2025

  6. Slide 6: Comprehensive Services Offering

    Comprehensive Services Offering Servicing Seniors Seniors Living Living Pharmacists Distribution Service Facilities Facilities Onsite geriatric-certified clinical A leading distributor of medical Automated dispensing pharmacists + pharmacist-led supplies and continence cabinets and medication medica

  7. Slide 7: Investment Highlights

    Investment Highlights 1 2 3 4 Differentiated Contracted Increasing Infrastructure & Strategy Recurring Revenue Demand Technology Largest pure-play 5+ year contract length Increasing seniors National platform with pharmacy focused on with largest customers population and best-in-class long-term care

  8. Slide 8: Differentiated Strategy

    Differentiated Strategy Retail Facility move-in consultation and specialized geriatric visits ✓  Deprescribing and routine medication reviews for safety & health ✓ ? 24/7 emergency medications and availability ✓  Free caregiver education and daily delivery ✓ ? Reduced errors with specialized packa

  9. Slide 9: Contracted Recurring Revenue

    Contracted Recurring Revenue • 5+ year contract length with largest customers funded by government payors • Capitated fee (fee/bed/month or fee-for-service) model for medications dispensed and clinical services • Payments billed directly to government and insurance • Non-covered medications paid for

  10. Slide 10: Increasing Demand

    Increasing Demand Currently CareRx 1,025,000 >500,000 88,000 beds congregate care beds in Canada1 18% Canada’s over 65 population is projected to grow by 2.7 million Current market has The Ontario government has over the next 5 years ~500,000 beds1 pledged to build 58,000 new or upgraded Spending on

  11. Slide 11: Infrastructure & Technology

    Infrastructure & Technology Key Technologies Supported by LTC Pharmacies • Unit dose “pouch” packaged medications PacMed BD Rowa (PacMed and BD Rowa Dose) Dose • eMAR software • Automated dispensing cabinets (ADCs) • Digital prescribing technologies (CPOE) • Medication incident management systems Te

  12. Slide 12: Growth Strategy

    Growth Strategy • Broadening scope of products and services (e.g. Revicare, BOOMR., etc.) Organic Bed Wins • Leverage scale & capabilities to provide superior pharmacy services offering • Increased focus on expansion to other congregate care settings • LTC occupancy increasing post-Covid Existing Pa

  13. Slide 13: Financial Performance

    Financial Performance Revenue Adj. EBITDA Operating Cash Flow $38.0 $381.7 $32.3 $370.7 $366.7 $30.3 $28.7 $27.4 $22.9 $262.6 $22.3 $7.3 FY '21 FY '22 FY '23 FY '24 FY '21 FY '22 FY '23 FY '24 FY '21 FY '22 FY '23 FY '24 Note: All figures in millions. 13 Organic growth and acquisitions driving cash

  14. Slide 14: Experienced Leadership Team

    Experienced Leadership Team Puneet Khanna Alpinder Grewal President & Chief Executive Officer Chief Operating Officer Former Chief Commercial Officer, COO and SVP, Corporate Joined CareRx in 2014 and has held various roles with Development of CareRx; former CEO of MED e-care Healthcare increasing re

  15. Slide 15: Capitalization

    Capitalization Ownership At March 31, 2025 Common Stock Ownership Shares Outstanding 62.7M Share Price1 C$2.70 Yorkville Asset Management 16,301,305 25.9% Market Cap C$169.4M Directors & Officers 6,764,043 10.7% Cash $11.1M Polar Asset Management 10,095,107 16.0% Debt $44.6M Other 29,835,616 47.4% T

  16. Slide 16: Ju\ ISTHE FUTURE OF SENIOR CARE & — i

    Ju\ ISTHE FUTURE OF SENIOR CARE & — i

CareRx — Investor Presentation (June 2025) on 6ix